We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Overexpressed PLAU and its potential prognostic value in head and neck squamous cell carcinoma.
- Authors
Zhexuan Li; Changhan Chen; Juncheng Wang; Ming Wei; Guancheng Liu; Yuexiang Qin; Li She; Yong Liu; Donghai Huang; Yongquan Tian; Gangcai Zhu; Xin Zhang
- Abstract
Background. Metastasis is a major event for survival and prognosis in patients with head and neck squamous cell carcinomas (HNSCC).Aprimary cause of metastasis is the proteolytic degradation of the extracellular matrix (ECM). The plasminogen activator urokinase (PLAU) is involved in the transformation of plasminogen to plasmin leading to hydrolyzation of ECM-related proteins. However, the role of PLAU expression in HNSCC is unclear and the worth being investigated. Methods. PLAU expression profiles and clinical parameters from multiple HNSCC datasets were used to investigate the relationship of PLAU expression and HNSCC survival. GO and PPI network were established on PLAU-related downstream molecular. The stroma score was deconvoluted for analysis of PLAU's association with the immune environment. ROC analysis was applied to show the performance of PLAU in predicting HNSCC prognosis. Results. PLAU mRNA was significantly elevated, as opposed to its methylation, in HNSCC tumor samples over normal specimens (all p < 0:01). Univariate and multivariate cox analysis showed PLAU could be an independent indicator for HNSCC prognosis. Combining with neck lymph node status, the AUC of PLAU in predicting 5-years overall survival reached to 0.862. GO enrichment analysis showed the major biological process (extracellular matrix organization and the P13K-Akt signaling pathway) may involve to the possible mechanism of PLAU's function on HNSCC prognosis. Furthermore, PLAU expression was positively correlated with stroma cell score, M1 type macrophages, and negatively associated with CD4 + T cell, Tregs cell, and follicular helper T cell. Conclusions. PLAU might be an independent biomarker for predicting outcomes of HNSCC patients. The elevated expression of PLAU was associated with HPV positivity and neck node status. The PI3K-Akt pathway and aberrant proportions of immune cells might underly the mechanism of PLAU's oncogene role in HNSCC.
- Subjects
PROGNOSIS; SQUAMOUS cell carcinoma; PROTEOLYSIS; PLASMINOGEN activators; NECK; OROPHARYNX
- Publication
PeerJ, 2021, p1
- ISSN
2167-8359
- Publication type
Article
- DOI
10.7717/peerj.10746